LIF supports primitive endoderm expansion during pre-implantation development

Area of Science:

• Developmental Biology
• Stem Cell Biology
• Cell Signaling

Background:

• Embryonic stem cells (ESCs) are pluripotent and require Leukemia inhibitory factor (LIF) for self-renewal in culture.
• ESCs are heterogeneous, containing multiple cell populations similar to blastocyst stages.
• Understanding LIF's targets is key to deciphering pluripotency maintenance.

Purpose of the Study:

• To identify the specific roles of LIF in embryonic stem cell populations and early embryo development.
• To elucidate the downstream signaling pathways affected by LIF.
• To understand how LIF influences the balance between epiblast and primitive endoderm lineages.

Main Methods:

• Culturing embryos with and without LIF, and with JAK/STAT signaling inhibitors.
• Analyzing cell populations using markers like GATA6 (primitive endoderm) and NANOG (epiblast).
• Assessing cell proliferation and apoptosis rates within embryonic tissues.

Main Results:

• LIF has distinct functions: blocking early epiblast differentiation and supporting primitive endoderm (PrE) expansion.
• JAK/STAT signaling, downstream of LIF, initially marks the pre-implantation embryo and later the PrE.
• LIF addition increases GATA6(+) PrE cells, while JAK/STAT inhibition reduces both NANOG(+) epiblast and GATA6(+) PrE cells.

Conclusions:

• LIF regulates embryonic lineage allocation by promoting PrE proliferation and inhibiting its apoptosis.
• The embryo adjusts primary lineage ratios, potentially based on the availability of LIF.
• This reveals a mechanism for controlling the relative sizes of epiblast and primitive endoderm lineages.